Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Biological predictors of response to antidepressants

Trial Profile

Biological predictors of response to antidepressants

Phase of Trial: Phase II

Latest Information Update: 16 Jun 2017

At a glance

  • Drugs Escitalopram (Primary) ; Desipramine
  • Indications Major depressive disorder
  • Focus Biomarker; Therapeutic Use
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 04 Apr 2012 Additional lead trial centre (New York State Psychiatric Institute) added as reported by ClinicalTrials.gov.
    • 04 Apr 2012 Planned end date changed from 1 Sep 2011 to 1 May 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top